130 related articles for article (PubMed ID: 36945158)
41. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
[TBL] [Abstract][Full Text] [Related]
42. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
43. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor.
Liu FY; Qi JP; Xu FL; Wu AP
World J Gastroenterol; 2006 Jul; 12(26):4161-5. PubMed ID: 16830365
[TBL] [Abstract][Full Text] [Related]
45. Imaging, morphologic, and immunohistochemical correlation in gastrointestinal stromal tumors.
Logrono R; Bhanot P; Chaya C; Cao L; Waxman I; Bhutani MS
Cancer; 2006 Aug; 108(4):257-66. PubMed ID: 16795074
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
48. The prognostic significance of pleomorphism in gastrointestinal stromal tumours.
Isidro RA; Hornick JL
Histopathology; 2022 Feb; 80(3):598-603. PubMed ID: 34562043
[TBL] [Abstract][Full Text] [Related]
49. MDCT and clinicopathological features of small bowel gastrointestinal stromal tumours in 102 patients: a single institute experience.
Baheti AD; Shinagare AB; O'Neill AC; Krajewski KM; Hornick JL; George S; Ramaiya NH; Tirumani SH
Br J Radiol; 2015 Sep; 88(1053):20150085. PubMed ID: 26111069
[TBL] [Abstract][Full Text] [Related]
50. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
51. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological characteristics of gastrointestinal mesenchymal tumors and diagnostic value of endoscopic ultrasonography.
Ji F; Wang ZW; Wang LJ; Ning JW; Xu GQ
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e318-24. PubMed ID: 18505417
[TBL] [Abstract][Full Text] [Related]
53. [Immunohistological and molecular genetic findings in GIST of the stomach].
Macák J; Wardelmann E; Gown MA
Cesk Patol; 2004 Oct; 40(4):143-8. PubMed ID: 15645847
[TBL] [Abstract][Full Text] [Related]
54. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis.
Yantiss RK; Spiro IJ; Compton CC; Rosenberg AE
Am J Surg Pathol; 2000 Jul; 24(7):947-57. PubMed ID: 10895817
[TBL] [Abstract][Full Text] [Related]
55. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.
Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L
World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848
[TBL] [Abstract][Full Text] [Related]
57. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
58. Abdominal monophasic synovial sarcoma is a morphological and immunohistochemical mimic of gastrointestinal stromal tumour.
Wong NA; Campbell F; Shepherd NA
Histopathology; 2015 Jun; 66(7):974-81. PubMed ID: 25346074
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of the Novel Monoclonal Antibody Against DOG1 as a Diagnostic Marker for Gastrointestinal Stromal Tumors.
Abdel-Hadi M; Bessa SS; Hamam SM
J Egypt Natl Canc Inst; 2009 Sep; 21(3):237-47. PubMed ID: 21132034
[TBL] [Abstract][Full Text] [Related]
60. [A clinical and immunohistochemical study on gastrointestinal stromal tumor].
Lee EJ; Lee OJ; Kim TH; Jung WT
Korean J Gastroenterol; 2003 Sep; 42(3):204-11. PubMed ID: 14532742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
